Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) — Free Cash Flow Generation Index

Latest as of September 2025: -96.08x

Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) has a Free Cash Flow Generation Index of -96.08x as of September 2025. Free cash flow of CN¥-52.24 Million represents -96% of operating cash flow (CN¥543.69K). Explore Suzhou Zelgen Biopharmaceuticals Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-96.08x

Free Cash Flow / Operating CF

Free Cash Flow

CN¥-52.24 Million

CNY

Operating Cash Flow

CN¥543.69K

CNY

Capital Expenditures

CN¥52.78 Million

CNY

Suzhou Zelgen Biopharmaceuticals Co Ltd Free Cash Flow Generation Index (2024–2024)

Historical FCF Generation Index trend for Suzhou Zelgen Biopharmaceuticals Co Ltd across 1 annual periods. For the full cash flow conversion analysis, see 688266 cash flow metrics.

Annual Free Cash Flow Generation for Suzhou Zelgen Biopharmaceuticals Co Ltd (2024–2024)

Year-by-year Free Cash Flow Generation Index for Suzhou Zelgen Biopharmaceuticals Co Ltd. Check 688266 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (CNY)	Operating CF	Capital Expenditures	YoY Change
2024	-1.50x	CN¥-57.49 Million	CN¥38.20 Million	CN¥95.69 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).